Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Migraine

Differential effects of placebos in migraine clinical trials

Subjects

According to a new systematic review, placebo treatment in clinical trials of migraine prophylaxis results in responder rates ranging from 0–56%, probably owing to variable combinations of spontaneous improvement and genuine placebo effects. Clinicians who treat patients with migraine should be aware of the potential nonspecific effects of any treatment modality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Slow clinical improvement in the placebo arms of three topiramate trials.

References

  1. Meissner, K. et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2013.10391.

  2. Krogsbøll, L. T., Hróbjartsson, A. & Gøtzsche, P. C. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med. Res. Methodol. 9, 1 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Linde, M., Mulleners, W. M., Chronicle, E. P. & McCrory, D. C. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews, Issue 6. Art. No.: CD010610 http://dx.doi.org/10.1002/14651858.CD010610.

  4. Macedo, A., Baños, J.-E. & Farré, M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur. J. Pain 12, 68–75 (2008).

    Article  PubMed  Google Scholar 

  5. Patel, S. M. et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol. Motil. 17, 332–340 (2005).

    Article  CAS  PubMed  Google Scholar 

  6. Linde, K. et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293, 2118–2125 (2005).

    Article  CAS  PubMed  Google Scholar 

  7. de Craen, A. J., Tijssen, J. G., de Gans, J. & Kleijnen, J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J. Neurol. 247, 183–188 (2000).

    Article  CAS  PubMed  Google Scholar 

  8. Diener, H.-C. et al. Topiramate in migraine prophylaxis—results from a placebo-controlled trial with propranolol as an active control. J. Neurol. 251, 943–950 (2004).

    Article  CAS  PubMed  Google Scholar 

  9. Tfelt-Hansen, P. et al. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia 32, 6–38 (2012).

    Article  PubMed  Google Scholar 

  10. Pradalier, A. et al. The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. CNS Drugs 18, 1149–1163 (2004).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peer C. Tfelt-Hansen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tfelt-Hansen, P., Hougaard, A. Differential effects of placebos in migraine clinical trials. Nat Rev Neurol 10, 10–11 (2014). https://doi.org/10.1038/nrneurol.2013.255

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.255

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing